Brief: Allergy Therapeutics Posts H1 Rev 34 Mln Stg
Jan 28 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ALLERGY THERAPEUTICS H1 REVENUE GBP 34 MILLION
* ALLERGY THERAPEUTICS: OVERALL SALES FOR FULL YEAR ENDING
ON 30
JUNE 2025 EXPECTED TO EXCEED SALES IN CORRESPONDING PERIOD ENDED
30 JUNE 2024
Source text: ID:nRSb8539Ua
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update